Apexium Financial’s Cognizant CTSH Stock Holding History

Apexium Financial’s Portfolio CTSH Stock Details CTSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,696	Closed	-$207K	–	280
2024 Q4	$207K	Hold	2,696	–	–	0.01%	251
2024 Q3	$208K	Buy	+2,696	New	+$201K	0.01%	225

Other funds holding CTSH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Apexium Financial's CTSH Position: Q1 2025 in Review

Apexium Financial sold out of Cognizant (CTSH) in Q1 2025, closing a stake of 2,696 shares — an estimated $207K sold.

Apexium Financial first reported a position in CTSH in Q3 2024 and held it in 2 quarters. The position peaked at $208K in Q3 2024. 1,005 funds tracked by Wall St. Rank hold CTSH as of Q1 2025.

Apexium Financial reported no remaining Cognizant position as of Q1 2025 after selling out during the quarter.
Apexium Financial sold 2,696 Cognizant shares in Q1 2025, an estimated $207K.
Apexium Financial first reported a position in Cognizant in Q3 2024 and held it in 2 quarters.
Apexium Financial's Cognizant position peaked at $208K in Q3 2024.
1,005 funds tracked by Wall St. Rank held Cognizant as of Q1 2025.

Based on Apexium Financial's 13F filing for Q1 2025, filed 14 May 2025.